TELA - TELA Bio bags biosynthetic mesh products agreement

• TELA Bio ( NASDAQ: TELA ) announced a three-year dual-source agreement in the biosynthetic category with one of the Nation’s group purchasing organizations (or GPO).
• The agreement, which runs through January 1, 2026, offers sizable growth opportunity over the contract period and provides their GPO members access to substantial cost savings and clinical differentiation.

For further details see: